A carregar...
Comparing the cost-effectiveness of rituximab maintenance and radio-immunotherapy consolidation versus observation following first-line therapy in follicular lymphoma patients
OBJECTIVES: Phase 3 randomized trials have shown that rituximab maintenance (MR) therapy or radio-immunotherapy (RIT) consolidation following frontline therapy can improve progression-free survival for patients with follicular lymphoma (FL), but the cost-effectiveness of these approaches with respec...
Na minha lista:
| Publicado no: | Value Health |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4363091/ https://ncbi.nlm.nih.gov/pubmed/25773554 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jval.2014.12.017 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|